Article
Predicting response to epigenetic therapy
1 Jan 2014
Abstract excerpt
Drugs targeting the epigenome are new promising cancer treatment modalities; however, not all patients receive the same benefit from these drugs. In contrast to conventional chemotherapy, responses may take several months after the initiation of treatment to occur. Accordingly, identification of good pretreatment predictors of response is of great value. Many clinical parameters and molecular targets have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.